Research Article
Bacitracin for Injection Recall: Impact on Immediate Breast Implant Surgical Outcomes
Table 6
Pre- and post-recall outcomes.
| | Total (n = 254) | Pre-recall (n = 172) | Post-recall (n = 82) | value |
| Complications | Any complication | 25 (9.84) | 17 (9.88) | 8 (9.76) | 0.952 | Infection | 18 (7.09) | 11 (6.40) | 7 (8.54) | 0.551 | Cellulitis | 9 (3.54) | 6 (3.49) | 3 (3.66) | 0.959 | Other complications | 10 (3.94) | 6 (3.49) | 4 (4.88) | 0.329 | Seroma | 5 (1.97) | 2 (1.16) | 3 (3.66) | | Hematoma | 3 (1.18) | 2 (1.16) | 1 (1.22) | | Delayed healing | 2 (0.79) | 2 (1.16) | 0 (0.00) | | Follow-up period, days | 296.22 ± 276.23 | 357.10 ± 307.64 | 168.51 ± 118.96 | <0.001 |
|
|
Bold values indicate statistical significance.
|